Evidence map›Paper›PMID 29667930›Full record

ArticleAging2018

KCNQ1OT1 promotes melanoma growth and metastasis.

Bingyu Guo, Qian Zhang, Hongyi Wang, Peng Chang, Kai Tao

RetractedOpen access · greenAbstract readRetracted Publication
In one paragraph

Article in Aging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Oncology research · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Bingyu GuoDepartment of Reconstructive and Plastic Surgery, The General Hospital of Shenyang Military Region, Shenyang, China.
Qian ZhangDepartment of Reconstructive and Plastic Surgery, The General Hospital of Shenyang Military Region, Shenyang, China.
Hongyi WangDepartment of Reconstructive and Plastic Surgery, The General Hospital of Shenyang Military Region, Shenyang, China.
Peng ChangDepartment of Reconstructive and Plastic Surgery, The General Hospital of Shenyang Military Region, Shenyang, China.
Kai TaoDepartment of Reconstructive and Plastic Surgery, The General Hospital of Shenyang Military Region, Shenyang, China.
General Hospital of Shenyang Military Region · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melanoma is the deadliest cutaneous neoplasm. To prevent metastasis, early diagnosis and surgical treatment is vital. Long non-coding RNAs (lncRNAs) may serve as biomarkers and therapeutic targets in tumors. We investigated the molecular mechanisms of lncRNA KCNQ1OT1 in melanoma. Real time PCR demonstrated that KCNQ1OT1 expression is up-regulated in melanoma tissues and cells. KCNQ1OT1 promoted cell proliferation and metastasis in melanoma. By directly bindin to miR-153, KCNQ1OT1 acted as a competing endogenous RNA (ceRNA) to de-repress MET expression. Our results may provide the basis for a novel strategy for early detection and/or treatment of melanoma.

Indexed as

AdultAgedAged, 80 and overAnimalsCell ProliferationCutaneous Malignant MelanomaFemaleGene Expression Regulation, NeoplasticHeterograftsHumansMaleMelanomaMiceMice, Inbred BALB CMice, NudeMicroRNAsKCNQ1OT1 long non-coding RNA, humanMicroRNAsMIRN153 microRNA, humanPotassium Channels, Voltage-GatedProto-Oncogene Proteins c-metKCNQ1OT1lncRNAmelanomamiR-153miRNA

Identifiers

PMID29667930
PMCPMC5940105
OpenAlexW2800512087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.